LEADER 01867nam  2200433 a 450 
001 9910702000003321
005 20120702110552.0
035   $a(CKB)5470000002422113
035   $a(OCoLC)797966013
035   $a(EXLCZ)995470000002422113
100   $a20120702d1978      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aBioassay of emetine for possible carcinogenicity$b[electronic resource] /$fCarcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
210  1$aBethesda, Md. :$cDept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health,$d1978.
215   $a1 online resource (ix, 108 pages) $cillustrations
225 1 $aCarcinogenesis technical report series ;$vno. 43
225 1 $aDHEW publication ;$vno. (NIH) 78-843
300   $aTitle from title screen (viewed on July 2, 2012).
300   $a"The Chemical Abstracts Service (CAS) Registry number used to track this bioassay is 316-42-7 which is determined to best define the material used in the conduct of this bioassay."
300   $a"CAS no. 483-18-1."
300   $a"NCI-CG-TR-43."
320   $aIncludes bibliographical references (pages 39-41).
606   $aCarcinogens
606   $aEmetine$xPhysiological effect
615  0$aCarcinogens.
615  0$aEmetine$xPhysiological effect.
712 02$aCarcinogenesis Testing Program (U.S.)
712 02$aNational Institutes of Health (U.S.)
712 02$aNational Cancer Institute (U.S.).$bDivision of Cancer Cause and Prevention.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910702000003321
996   $aBioassay of emetine for possible carcinogenicity$93092284
997   $aUNINA